Kempton, C., Trask, P., Parnes, A., Niggli, M., Campinha‐Bacote, A., U. Callaghan, M., . . . Mahlangu, J. N. (2021). Development and testing of the Satisfaction Questionnaire with Intravenous or Subcutaneous Hemophilia Injection and results from the Phase 3 HAVEN 3 study of emicizumab prophylaxis in persons with haemophilia A without FVIII inhibitors. Haemophilia.
Citação norma ChicagoKempton, Christine, Peter Trask, Aric Parnes, Markus Niggli, Avrita Campinha‐Bacote, Michael U. Callaghan, Niamh O'Connell, Ido Paz‐Priel, and Johnny N. Mahlangu. "Development and Testing of the Satisfaction Questionnaire With Intravenous or Subcutaneous Hemophilia Injection and Results From the Phase 3 HAVEN 3 Study of Emicizumab Prophylaxis in Persons With Haemophilia A Without FVIII Inhibitors." Haemophilia 2021.
Citação norma MLAKempton, Christine, et al. "Development and Testing of the Satisfaction Questionnaire With Intravenous or Subcutaneous Hemophilia Injection and Results From the Phase 3 HAVEN 3 Study of Emicizumab Prophylaxis in Persons With Haemophilia A Without FVIII Inhibitors." Haemophilia 2021.